BACKGROUND: Malawi malaria treatment guidelines recommend a definitive diagnosis, using a malaria rapid diagnostic test (mRDT), for all patients with fever or history of fever. Improving the management and outcomes of febrile children with negative mRDT results should be a priority. METHODS: Through a prospective cohort study designed to investigate clinical outcomes of children treated at the community level, we followed, for 7 days, children aged 2 to 59 months, who had negative mRDT results and were treated with antipyretic medication. Clinical outcomes were assessed on days 3 and 7 post-recruitment. RESULTS: The median age of recruited children was 19 months. Of the 285 children enrolled, 139 (48.8%) were females. Of the children for whom data were available for analysis, 95/236 (40.3%) had fever (temperature ≥ 37.5°C) at enrolment, and almost half of the sick children (125/268; 46.6%) had symptoms of upper respiratory tract infection. Most sick children (89.6%; 95% confidence interval, CI = 84.2 to 93.3) recovered, while 10.4% (95% CI: 6.7 to 15.8) were still sick by day 7 of follow-up. There were no deaths reported during the 7 days of follow-up. Being afebrile at enrolment (odds ratio, OR = 2.5; 95% CI = 1.1 to 6.0; P = 0.027) and sleeping under an insecticide-treated net (ITN) (OR = 2.7; 95% CI = 1.2 to 6.2; P = 0.011) were associated with recovery by day 7. In multivariable analysis, sleeping under an ITN the previous night was the only factor associated with recovery by day 7. Microscopy did not detect any malaria parasites in the blood of recruited children, at recruitment or on day 7. CONCLUSIONS: In this community-level study, the majority of febrile children with negative mRDT results recovered within 7 days of health worker consultation for a febrile illness, having only taken antipyretics.
BACKGROUND:Malawi malaria treatment guidelines recommend a definitive diagnosis, using a malaria rapid diagnostic test (mRDT), for all patients with fever or history of fever. Improving the management and outcomes of febrile children with negative mRDT results should be a priority. METHODS: Through a prospective cohort study designed to investigate clinical outcomes of children treated at the community level, we followed, for 7 days, children aged 2 to 59 months, who had negative mRDT results and were treated with antipyretic medication. Clinical outcomes were assessed on days 3 and 7 post-recruitment. RESULTS: The median age of recruited children was 19 months. Of the 285 children enrolled, 139 (48.8%) were females. Of the children for whom data were available for analysis, 95/236 (40.3%) had fever (temperature ≥ 37.5°C) at enrolment, and almost half of the sick children (125/268; 46.6%) had symptoms of upper respiratory tract infection. Most sick children (89.6%; 95% confidence interval, CI = 84.2 to 93.3) recovered, while 10.4% (95% CI: 6.7 to 15.8) were still sick by day 7 of follow-up. There were no deaths reported during the 7 days of follow-up. Being afebrile at enrolment (odds ratio, OR = 2.5; 95% CI = 1.1 to 6.0; P = 0.027) and sleeping under an insecticide-treated net (ITN) (OR = 2.7; 95% CI = 1.2 to 6.2; P = 0.011) were associated with recovery by day 7. In multivariable analysis, sleeping under an ITN the previous night was the only factor associated with recovery by day 7. Microscopy did not detect any malaria parasites in the blood of recruited children, at recruitment or on day 7. CONCLUSIONS: In this community-level study, the majority of febrile children with negative mRDT results recovered within 7 days of health worker consultation for a febrile illness, having only taken antipyretics.
Authors: D Mukanga; R Babirye; S Peterson; G W Pariyo; G Ojiambo; J K Tibenderana; P Nsubuga; K Kallander Journal: Trop Med Int Health Date: 2011-07-14 Impact factor: 2.622
Authors: Helen Counihan; Steven A Harvey; Masela Sekeseke-Chinyama; Busiku Hamainza; Rose Banda; Thindo Malambo; Freddie Masaninga; David Bell Journal: Am J Trop Med Hyg Date: 2012-07 Impact factor: 2.345
Authors: Esmée Ruizendaal; Susan Dierickx; Koen Peeters Grietens; Henk D F H Schallig; Franco Pagnoni; Petra F Mens Journal: Malar J Date: 2014-06-12 Impact factor: 2.979
Authors: Youssoupha Ndiaye; Jean L A Ndiaye; Badara Cisse; Demetri Blanas; Jonas Bassene; Isaac A Manga; Mansour Ndiath; Sylvain L Faye; Mamoudou Bocoum; Mouhamed Ndiaye; Pape M Thior; Doudou Sene; Paul Milligan; Omar Gaye; David Schellenberg Journal: Malar J Date: 2013-07-12 Impact factor: 2.979
Authors: Themba B Phiri; Blessings N Kaunda-Khangamwa; Andrew Bauleni; Tiyese Chimuna; David Melody; Humphreys Kalengamaliro; John H Sande; Humphreys Kampira Nsona; Don P Mathanga Journal: Malar J Date: 2016-03-21 Impact factor: 2.979
Authors: Arthur Mpimbaza; Susan Nayiga; Grace Ndeezi; Philip J Rosenthal; Charles Karamagi; Anne Katahoire Journal: PLoS One Date: 2019-06-05 Impact factor: 3.240
Authors: Arjun Chandna; Rainer Tan; Paul Turner; Kristina Keitel; Michael Carter; Ann Van Den Bruel; Jan Verbakel; Constantinos Koshiaris; Nahya Salim; Yoel Lubell Journal: BMJ Glob Health Date: 2021-01